Cargando…
_version_ 1784844276968980480
author Schriek, Angela I.
van Haaren, Marlies M.
Poniman, Meliawati
Dekkers, Gillian
Bentlage, Arthur E. H.
Grobben, Marloes
Vidarsson, Gestur
Sanders, Rogier W.
Verrips, Theo
Geijtenbeek, Teunis B. H.
Heukers, Raimond
Kootstra, Neeltje A.
de Taeye, Steven W.
van Gils, Marit J.
author_facet Schriek, Angela I.
van Haaren, Marlies M.
Poniman, Meliawati
Dekkers, Gillian
Bentlage, Arthur E. H.
Grobben, Marloes
Vidarsson, Gestur
Sanders, Rogier W.
Verrips, Theo
Geijtenbeek, Teunis B. H.
Heukers, Raimond
Kootstra, Neeltje A.
de Taeye, Steven W.
van Gils, Marit J.
author_sort Schriek, Angela I.
collection PubMed
description
format Online
Article
Text
id pubmed-9723857
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97238572022-12-07 Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions Schriek, Angela I. van Haaren, Marlies M. Poniman, Meliawati Dekkers, Gillian Bentlage, Arthur E. H. Grobben, Marloes Vidarsson, Gestur Sanders, Rogier W. Verrips, Theo Geijtenbeek, Teunis B. H. Heukers, Raimond Kootstra, Neeltje A. de Taeye, Steven W. van Gils, Marit J. Front Immunol Immunology Frontiers Media S.A. 2022-11-22 /pmc/articles/PMC9723857/ /pubmed/36483568 http://dx.doi.org/10.3389/fimmu.2022.1091668 Text en Copyright © 2022 Schriek, van Haaren, Poniman, Dekkers, Bentlage, Grobben, Vidarsson, Sanders, Verrips, Geijtenbeek, Heukers, Kootstra, de Taeye and van Gils https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Schriek, Angela I.
van Haaren, Marlies M.
Poniman, Meliawati
Dekkers, Gillian
Bentlage, Arthur E. H.
Grobben, Marloes
Vidarsson, Gestur
Sanders, Rogier W.
Verrips, Theo
Geijtenbeek, Teunis B. H.
Heukers, Raimond
Kootstra, Neeltje A.
de Taeye, Steven W.
van Gils, Marit J.
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
title Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
title_full Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
title_fullStr Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
title_full_unstemmed Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
title_short Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
title_sort corrigendum: anti-hiv-1 nanobody-igg1 constructs with improved neutralization potency and the ability to mediate fc effector functions
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723857/
https://www.ncbi.nlm.nih.gov/pubmed/36483568
http://dx.doi.org/10.3389/fimmu.2022.1091668
work_keys_str_mv AT schriekangelai corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT vanhaarenmarliesm corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT ponimanmeliawati corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT dekkersgillian corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT bentlagearthureh corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT grobbenmarloes corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT vidarssongestur corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT sandersrogierw corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT verripstheo corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT geijtenbeekteunisbh corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT heukersraimond corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT kootstraneeltjea corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT detaeyestevenw corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions
AT vangilsmaritj corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions